448 related articles for article (PubMed ID: 12234996)
1. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
[TBL] [Abstract][Full Text] [Related]
2. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
[TBL] [Abstract][Full Text] [Related]
3. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene.
Lin L; Aggarwal S; Glover TW; Orringer MB; Hanash S; Beer DG
Cancer Res; 2000 Mar; 60(5):1341-7. PubMed ID: 10728696
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.
Lin L; Prescott MS; Zhu Z; Singh P; Chun SY; Kuick RD; Hanash SM; Orringer MB; Glover TW; Beer DG
Cancer Res; 2000 Dec; 60(24):7021-7. PubMed ID: 11156406
[TBL] [Abstract][Full Text] [Related]
5. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
[TBL] [Abstract][Full Text] [Related]
6. Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia.
Miller CT; Moy JR; Lin L; Schipper M; Normolle D; Brenner DE; Iannettoni MD; Orringer MB; Beer DG
Clin Cancer Res; 2003 Oct; 9(13):4819-25. PubMed ID: 14581353
[TBL] [Abstract][Full Text] [Related]
7. ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
[TBL] [Abstract][Full Text] [Related]
8. Molecular dissection of 17q12 amplicon in upper gastrointestinal adenocarcinomas.
Maqani N; Belkhiri A; Moskaluk C; Knuutila S; Dar AA; El-Rifai W
Mol Cancer Res; 2006 Jul; 4(7):449-55. PubMed ID: 16849520
[TBL] [Abstract][Full Text] [Related]
9. Gene amplification in gastric and esophageal adenocarcinomas.
Houldsworth J; Cordon-Cardo C; Ladanyi M; Kelsen DP; Chaganti RS
Cancer Res; 1990 Oct; 50(19):6417-22. PubMed ID: 2400999
[TBL] [Abstract][Full Text] [Related]
10. BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line.
Kawasaki T; Yokoi S; Tsuda H; Izumi H; Kozaki K; Aida S; Ozeki Y; Yoshizawa Y; Imoto I; Inazawa J
Cancer Sci; 2007 Jul; 98(7):1070-7. PubMed ID: 17459056
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines.
Yang ZQ; Imoto I; Fukuda Y; Pimkhaokham A; Shimada Y; Imamura M; Sugano S; Nakamura Y; Inazawa J
Cancer Res; 2000 Sep; 60(17):4735-9. PubMed ID: 10987278
[TBL] [Abstract][Full Text] [Related]
12. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
13. Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.
Lin J; Lin L; Thomas DG; Greenson JK; Giordano TJ; Robinson GS; Barve RA; Weishaar FA; Taylor JM; Orringer MB; Beer DG
Clin Cancer Res; 2004 Sep; 10(17):5708-16. PubMed ID: 15355897
[TBL] [Abstract][Full Text] [Related]
14. High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.
Hayashi K; Metzger R; Salonga D; Danenberg K; Leichman LP; Fink U; Sendler A; Kelsen D; Schwartz GK; Groshen S; Lenz HJ; Danenberg PV
Oncogene; 1997 Sep; 15(12):1481-8. PubMed ID: 9333024
[TBL] [Abstract][Full Text] [Related]
15. Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction.
van Dekken H; Tilanus HW; Hop WC; Dinjens WN; Wink JC; Vissers KJ; van Marion R
Cancer Genet Cytogenet; 2009 Feb; 189(1):37-42. PubMed ID: 19167610
[TBL] [Abstract][Full Text] [Related]
16. Multiple forms of genetic instability within a 2-Mb chromosomal segment of 3q26.3-q27 are associated with development of esophageal adenocarcinoma.
Lin L; Wang Z; Prescott MS; van Dekken H; Thomas DG; Giordano TJ; Chang AC; Orringer MB; Gruber SB; Moran JV; Glover TW; Beer DG
Genes Chromosomes Cancer; 2006 Apr; 45(4):319-31. PubMed ID: 16320248
[TBL] [Abstract][Full Text] [Related]
17. Identification of ZASC1 encoding a Krüppel-like zinc finger protein as a novel target for 3q26 amplification in esophageal squamous cell carcinomas.
Imoto I; Yuki Y; Sonoda I; Ito T; Shimada Y; Imamura M; Inazawa J
Cancer Res; 2003 Sep; 63(18):5691-6. PubMed ID: 14522885
[TBL] [Abstract][Full Text] [Related]
18. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
[TBL] [Abstract][Full Text] [Related]
19. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
[TBL] [Abstract][Full Text] [Related]
20. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
